The largest database of trusted experimental protocols

Si fen1

Manufactured by RiboBio
Sourced in China

Si-FEN1 is a laboratory equipment designed to facilitate the study of DNA repair mechanisms. The core function of this product is to enable the analysis of the activity and regulation of the FEN1 (Flap Endonuclease 1) enzyme, which plays a crucial role in DNA repair pathways.

Automatically generated - may contain errors

2 protocols using si fen1

1

Osteosarcoma Cell Line Transfection

Check if the same lab product or an alternative is used in the 5 most similar protocols
The human MG-63, U2OS and 143B cell lines were purchased from American Type Culture Collection (Manassas, VA, USA). Cells were cultured in Dulbecco’s modified Eagle’s medium (DMEM) supplemented with 10% fetal bovine serum (Invitrogen; Thermo Fisher Scientific, USA.) and 1% penicillin and streptomycin and maintained at 37°C in a humidified incubator with 5% CO2. The miR-193b mimic, miR-193b inhibitor, and negative control were designed and synthesized by Guangzhou RiboBio Co., Ltd (Guangzhou, China). The small interfering RNA (siRNA) targeting FEN1 (si-FEN1) and negative control (NC) siRNA were also synthesized by Guangzhou RiboBio Co., Ltd. Plasmids for FEN1 and NC overexpression were purchased from Shanghai GenePharma Co., Ltd. All plasmid constructs were verified by sequencing. Lipofectamine® 2000 (Invitrogen; Thermo Fisher Scientific, Inc.) was used for miRNA or siRNA transfection into OS cells according to the manufacturer’s protocols. Cells were harvested for subsequent experiments 48 h after transfection.
+ Open protocol
+ Expand
2

Cell Culture and Drug Treatment Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
American Type Culture Collection (ATCC, Manassas, VA, USA) provided the human MG-63, U2OS and 143B OS cell lines. The cells were cultured in Dulbecco’s modified Eagle’s medium (DMEM) supplemented with 10% fetal bovine serum (Invitrogen; Thermo Fisher Scientific, Carlsbad, CA, USA) and maintained at 37°C in a humidified incubator with 5% CO2 (link). The miR-610 mimic, miR-610 inhibitor, and negative control were designed and synthesised by Guangzhou RiboBio Co., Ltd (Science City, Guangzhou, China), along with the small interfering RNA (siRNA) targeting FEN1 and IGF-1R (si-FEN1, si-IGF1R) and negative control (NC) siRNA. All plasmid constructs were verified by sequencing. Lipofectamine 2000 (Invitrogen, USA) was used for each miRNA or siRNA transfection according to the manufacturer’s protocol. Cells were harvested for subsequent experiments 48 h after transfection or anti-cancer drug treatment [Metformin 10 mM, ADM (0.7095 μM for MG-63, 0.9787 μM for U2OS), DDP (0.9731 μM for MG-63, 1.018 μM for U2OS), MTX (35.68 μM for MG-63, 33.54 μM for U2OS)]. Metformin, ADM, DDP and MTX were purchased from Sigma-Aldrich (St. Louis, MO, USA). The drugs were prepared immediately before use. The FEN1, IGF-1R, cleaved caspase-3, and GAPDH antibodies were obtained from Abcam (Cambridge, MA, USA).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!